US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Aldeyra Therapeutics Inc (ALDX)
Aldeyra Therapeutics Inc (ALDX) ニュース

ALDX

Aldeyra Therapeutics (ALDX)

Aldeyra Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ALDX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/02	21 : 00	Business Wire	Aldeyra Therapeutics to Participate in the Citi 2024 Global Healthcare Conference	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/11/18	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/11/18	21 : 00	Business Wire	Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/11/14	21 : 00	Business Wire	Aldeyra Therapeutics to Participate in the Jefferies London Healthcare Conference	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/11/08	06 : 02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/10/31	20 : 00	Business Wire	Aldeyra Therapeutics Selected to Present at the Disruptive Innovations Symposium during the OSN New York Retina 2024 Meeting	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/10/22	09 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/10/03	20 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/10/03	20 : 00	Business Wire	Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/10/03	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/09/11	05 : 15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/09/05	20 : 00	Business Wire	Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/09/03	22 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/08/15	05 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/08/15	05 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/08/13	07 : 07	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/08/13	06 : 45	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/08/08	20 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/08/08	20 : 00	Business Wire	Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Clinical Trial of Reproxalap	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/08/08	05 : 01	Business Wire	Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from the Phase 3 Dry Eye Chamber Clinical Trial of Reproxalap	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/08/02	06 : 01	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/08/02	05 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/08/02	05 : 03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/06/20	20 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/06/20	20 : 00	Business Wire	Aldeyra Therapeutics Announces Advancement of New RASP Modulators and Recent Preclinical Data in Obesity at 2024 Investor Roundtable	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/06/13	20 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/06/13	20 : 00	Business Wire	Aldeyra Therapeutics Completes Enrollment in Phase 3 Clinical Trial of Reproxalap in Dry Eye Disease	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/06/12	20 : 00	Business Wire	Aldeyra Therapeutics to Host Investor Roundtable Q&A	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/06/08	05 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALDX	Aldeyra Therapeutics Inc
2024/06/07	05 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALDX	Aldeyra Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:ALDX

1 2 3 4 5 6 7 8 9 10 次へ >>

Gold vs US Dollar

American Express

JP Morgan Chase

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約